Lena Wu
Gründer bei Intabio, Inc.
Profil
Lena Wu is the founder of Intabio, Inc. She is currently the Director at Matterworks, Inc. since 2021.
Previously, she worked as the Director of Business Development at Caliper Technologies Corp.
and as a Principal at Millennium Pharmaceuticals, Inc. She also served as the Vice President of Corporate Development at Cellective Dx Corp.
Dr. Wu completed her undergraduate and doctorate degrees at Stanford University.
Aktive Positionen von Lena Wu
| Unternehmen | Position | Beginn |
|---|---|---|
Intabio, Inc.
 Intabio, Inc. Miscellaneous Commercial ServicesCommercial Services Intabio, Inc. develops bio therapeutic drugs. The frim utilizes microchip platform to seamlessly integrate capillary isoelectric focusing (cIEF) and mass spec, two pillars of analytical methods in biopharmaceutical development and manufacturing. The company was founded by Lena Wu and Erik Gentalen and is headquartered in Newark, CA. | Gründer | - |
Matterworks, Inc.
 Matterworks, Inc. Miscellaneous Commercial ServicesCommercial Services Matterworks, Inc. is a biotechnology company that specializes in metabolomics screening. The company is based in Somerville, MA. The company was founded by Jack Geremia and Mimoun Cadosch Delmar, with Jack Geremia serving as the CEO since incorporation. | Direktor/Vorstandsmitglied | 01.10.2021 |
Ehemalige bekannte Positionen von Lena Wu
| Unternehmen | Position | Ende |
|---|---|---|
Cellective Dx Corp.
 Cellective Dx Corp. Pharmaceuticals: GenericHealth Technology Informed decisions will improve the way cancer is treated. On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its platform will enable better decision-making across multiple cancers: improving the cost of treatment, the quality of life for patients and ultimately increasing survival. Products currently in development are based on two core technologies: 1) DNA repair biomarkers that predict treatment response and 2) Microfluidic chip technology that enables capture, enumeration and characterization of circulating tumor cells (CTCs) in the bloodstream. | Corporate Officer/Principal | 03.11.2009 |
Caliper Technologies Corp.
 Caliper Technologies Corp. Medical SpecialtiesHealth Technology Caliper Technologies Corp. is a leading provider of microfluidic technology and laboratory automation solutions. The private company is based in Mountain View, CA. The company serves a broad range of markets in the worldwide life science, biotechnology, and pharmaceutical industries. The company was founded by J. Michael Ramsey. | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Lena Wu
| Stanford University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Cellective Dx Corp.
Cellective Dx Corp. Pharmaceuticals: GenericHealth Technology Informed decisions will improve the way cancer is treated. On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its platform will enable better decision-making across multiple cancers: improving the cost of treatment, the quality of life for patients and ultimately increasing survival. Products currently in development are based on two core technologies: 1) DNA repair biomarkers that predict treatment response and 2) Microfluidic chip technology that enables capture, enumeration and characterization of circulating tumor cells (CTCs) in the bloodstream. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Caliper Technologies Corp.
Caliper Technologies Corp. Medical SpecialtiesHealth Technology Caliper Technologies Corp. is a leading provider of microfluidic technology and laboratory automation solutions. The private company is based in Mountain View, CA. The company serves a broad range of markets in the worldwide life science, biotechnology, and pharmaceutical industries. The company was founded by J. Michael Ramsey. | Health Technology |
Intabio, Inc.
Intabio, Inc. Miscellaneous Commercial ServicesCommercial Services Intabio, Inc. develops bio therapeutic drugs. The frim utilizes microchip platform to seamlessly integrate capillary isoelectric focusing (cIEF) and mass spec, two pillars of analytical methods in biopharmaceutical development and manufacturing. The company was founded by Lena Wu and Erik Gentalen and is headquartered in Newark, CA. | Commercial Services |
Matterworks, Inc.
Matterworks, Inc. Miscellaneous Commercial ServicesCommercial Services Matterworks, Inc. is a biotechnology company that specializes in metabolomics screening. The company is based in Somerville, MA. The company was founded by Jack Geremia and Mimoun Cadosch Delmar, with Jack Geremia serving as the CEO since incorporation. | Commercial Services |
